🧬 Aging Wiki

telangiectasia

Properties1
aliasesspider veins, vascular ectasia, spider telangiectasia, matted telangiectasia, spider naevus

21 min read

Disambiguation: This page covers telangiectasia as a vascular structural phenotype — the permanently dilated, ectatic small blood vessels that appear as red, violaceous, or blue markings on the skin surface (“spider veins,” matted telangiectasia, photodamage-associated facial vessels). It does not cover ataxia-telangiectasia — the ATM-deficiency hereditary syndrome causing cerebellar ataxia, immunodeficiency, and radiation sensitivity — which is the referent of most “telangiectasia” mentions in this wiki’s DNA-damage and genomic-instability pages. It also does not cover hereditary hemorrhagic telangiectasia (HHT; ICD-10 I78.0; Osler-Weber-Rendu syndrome, caused by ACVRL1/ENG loss-of-function in the TGF-β/BMP pathway, presenting with mucocutaneous telangiectasia and arteriovenous malformations). Both ATM-related and HHT telangiectasia are genetically determined multi-system diseases, distinct from the acquired, UV-driven and aging-associated vascular phenotype described here.

Telangiectasia (vascular lesion)

Telangiectasias are permanently dilated small blood vessels — capillaries, post-capillary venules, and occasionally arterioles — that have become ectatic and fixed in a dilated state at or just below the skin surface, producing visible vascular markings 0.1–1 mm in diameter. They are among the most common vascular signs of facial photoaging and rosacea, affecting the great majority of fair-skinned adults with chronic sun exposure by the sixth or seventh decade. Unlike cherry angiomas — discrete vascular tumors driven by somatic GNAQ/GNA11/GNA14 activating mutations — telangiectasias arise from structural failure of the perivascular support matrix rather than from neoplastic endothelial proliferation, a distinction that is mechanistically important and that explains why laser treatment can permanently ablate them without stimulating replacement neoplastic growth.

Treatment is effective and durable. Vascular light and laser therapies exploit selective photothermolysis — delivering a wavelength preferentially absorbed by oxyhemoglobin in a pulse shorter than the thermal relaxation time of the target vessel — to thermally destroy ectatic vessels while sparing the surrounding dermis 1. Pulsed-dye laser (PDL, ~585–595 nm), potassium-titanyl-phosphate (KTP / frequency-doubled Nd:YAG, 532 nm), long-pulsed Nd:YAG (1064 nm), and intense pulsed light (IPL) are the established modalities. Sclerotherapy is the treatment of choice for leg telangiectasias.

Clinical types and anatomic distribution

Photodamage-associated facial telangiectasia

The most common form in aging adults. Cumulative UVA/UVB exposure — see skin-aging for the full UV→MMP→collagen-loss axis — drives dermal matrix metalloproteinase (MMP) upregulation, collagen and elastic fiber fragmentation, and progressive degradation of the perivascular fibrous scaffold that normally maintains superficial capillaries in a toned, non-ectatic state. As this support is lost, vessels dilate passively under prevailing capillary and arteriolar pressure and become structurally fixed in the ectatic state. Characteristic locations: bilateral cheeks, nasal ala and nasal tip, perialar skin, and central face. Lesions are typically fine, linear, arborizing, or stellate (“spider”). Fitzpatrick skin phototype I–II and a history of chronic or occupational UV exposure are the dominant risk modifiers. gap/needs-replication for a primary source directly quantifying perivascular matrix architecture vs telangiectasia density in UV-aged vs sun-protected skin.

Closely related is poikiloderma of Civatte — a triad of diffuse erythema, telangiectasia, and dyspigmentation (reticulate hyperpigmentation interspersed with epidermal atrophy) on the lateral neck and décolletage, with conspicuous sparing of the shaded submental triangle (confirming the UV etiology). The combination reflects long-term photodamage amplified by fragrance-containing cosmetics (photocontact sensitization is a cofactor in many cases). It is coded separately as ICD-10 L57.5 under the photoaging block. IPL is considered first-line for poikiloderma of Civatte, simultaneously addressing both the telangiectatic and pigmentary components, with >75% clearance achieved in clinical series 23.

Rosacea-associated telangiectasia

A cardinal feature of erythematotelangiectatic rosacea (ETR) and rosacea with vascular involvement — see rosacea. Unlike photodamage forms, rosacea telangiectasia arise within a context of chronic neurovascular dysregulation, mast cell activation, Demodex folliculorum colonization, and TLR-2/kallikrein-5 innate-immune cascade-driven inflammation, producing persistent vasodilatation that eventually results in irreversible structural ectasia. The erythematous and telangiectatic components are mechanistically distinct: diffuse transient erythema reflects episodic vasodilation (partially suppressed by topical brimonidine); fixed telangiectasias are permanent structural lesions that brimonidine does not reverse or clear 4. Vascular laser and IPL are the only modalities that durably address fixed rosacea-associated telangiectasia 4.

Leg telangiectasia (spider veins)

Lower-extremity telangiectasias and reticular veins represent the mildest end of the chronic-venous-disease spectrum — CEAP class C1 in the clinical staging system. They are driven by ambulatory venous hypertension and valve incompetence, which chronically elevate capillary and post-capillary venule pressure in the skin of the lower leg and foot (see chronic-venous-disease for the full pathophysiologic loop). Population-based data from the Bonn Vein Study (n≈3,000, ages 18–79) show CEAP C1 in approximately 59% of adults, making them the most prevalent vascular skin finding in the population 5. Women have substantially higher odds than men for spider veins specifically (OR ~5.4 in the San Diego Population Study 6), with pregnancy, prolonged standing, and family history as additional risk factors. Sclerotherapy is the primary treatment for leg telangiectasias; laser is an alternative for vessels too small or superficially located to inject safely 78.

Generalized essential telangiectasia

A rare, idiopathic, progressive form in which telangiectasias spread over large body-surface areas in the absence of recognized systemic disease, UV correlation, or venous hypertension. Primarily affects women; familial cases described. No mechanism-based treatment exists; vascular laser therapies are palliative. Must be distinguished from HHT (hereditary, mucosal involvement, arteriovenous malformations), CREST syndrome telangiectasia (associated with limited systemic sclerosis; anti-centromere antibody positive), and hereditary benign telangiectasia. This form is not discussed further here.

Spider naevus (spider angioma; plural: spider naevi) consists of a central pulsating arteriole with thin-walled branches radiating outward — the “spider legs.” The defining bedside sign is blanching on firm central pressure, followed by centrifugal refilling from the arteriolar center when pressure is released; this directional refill pattern distinguishes spider naevi from venous or photodamage telangiectasia, which do not pulsate or refill centrifugally. Spider naevi are a cutaneous hallmark of chronic liver disease, present in approximately 30–40% of cirrhotic patients, with approximately 95% specificity for cirrhosis 9. They cluster in the superior vena cava (SVC) drainage territory — face (cheeks, nose, perioral skin), neck, upper chest, and arms — reflecting the arterial supply pattern of that anatomical zone.

Mechanism: hyperestrogenemia, substance P, and VEGF. Three partially overlapping mediators converge in cirrhosis to produce spider naevi:

  1. Hyperestrogenemia. The cirrhotic liver cannot adequately catabolize estradiol. Concurrently, elevated sex hormone-binding globulin (SHBG) suppresses free testosterone proportionally more than free estradiol, shifting the free estradiol/free testosterone ratio toward feminization. In male cirrhotic patients, this ratio is significantly higher in those with spider naevi, gynecomastia, and palmar erythema than in those without 1011. Estrogens promote vasodilation and increase cutaneous vascularity, providing the permissive hormonal background for arteriolar ectasia.

  2. Substance P. Plasma substance P is elevated approximately 2.4-fold in cirrhotic patients versus healthy controls (median 29.2 vs 12.3 pg/mL), and is highest in those with spider angiomas. In stepwise logistic regression it was the only significant independent predictor of spider angioma presence (OR 3.0, 95% CI 1.4–6.6, p=0.01); sex hormone ratios, nitrate/nitrite, and haemodynamic parameters were not retained in the model 12. Note: this study was conducted specifically in nonalcoholic liver cirrhosis; applicability to alcoholic cirrhosis is inferred but not directly demonstrated by this source. Substance P acts on NK-1 receptors on vascular endothelium and smooth muscle, producing vasodilation and pro-angiogenic signalling.

  3. VEGF and bFGF. Cirrhotic patients with spider angiomas have markedly elevated plasma VEGF (185 ± 28 pg/mL) versus cirrhotic patients without (90 ± 10 pg/mL) and healthy controls (71 ± 11 pg/mL). Basic fibroblast growth factor (bFGF) shows the same gradient (6.8 ± 1.0 vs 4.1 ± 0.5 pg/mL with vs without spider angiomas). In multivariate logistic regression, young age (≤60 years, OR 6.64) was the strongest independent predictor, with VEGF (OR 4.35) and bFGF (OR 5.66) also independently significant — indicating that age-related decline in angiogenic capacity interacts with neoangiogenic growth-factor excess to determine spider angioma formation 13.

Number correlates with disease severity. Spider naevi count correlates with hepatic dysfunction severity: serum bilirubin is an independent predictor of spider angioma presence (OR 2.8) alongside alcoholism (OR 3.5) 11. Spider naevi contribute to the additive Combined Clinical and Laboratory Index (CCLI) severity score for alcoholic liver disease (alongside edema, ascites, encephalopathy, and laboratory markers), and their presence was associated with higher univariate mortality risk in the Orrego 1983 cohort 14; however, in that study’s stepwise discriminant function and logistic regression analyses, spider nevi were not retained as independent multivariate predictors — the independent predictors were encephalopathy, albumin, prothrombin time, and hemoglobin. Noninvasive assessment literature lists spider naevi as a clinical predictor of oesophageal varices in cirrhosis, though formal performance metrics require further validation against endoscopy 15.

Post-cessation course: reversibility vs. permanence. Spider naevi differ critically from the UV-driven and venous telangiectasia covered elsewhere on this page:

  • Potentially reversible with hepatic recovery: when liver function improves with sustained alcohol abstinence in early or compensated cirrhosis — or following liver transplantation — the hyperestrogenemia, elevated VEGF, and elevated substance P that drive spider naevi can normalise, and lesions may regress. The underlying driver is dysfunctional hepatic hormone metabolism, which is partly functional and may recover, not purely irreversible structural vessel change.
  • Persist or multiply with established or progressive cirrhosis: in decompensated cirrhosis or with continued alcohol use, liver damage is not reversible and spider naevi persist. New lesions signal ongoing hepatic deterioration and carry adverse prognostic significance.
  • Contrast with photodamage and venous telangiectasia: UV-induced facial telangiectasia and leg spider veins (CEAP C1) arise from perivascular collagen loss and venous hypertension — structural changes that do not regress when the causal exposure (UV, ambulatory venous pressure) is reduced. Those forms require laser ablation or sclerotherapy regardless of lifestyle change. Hepatic spider naevi thus occupy a distinct position: disease reversal (hepatic recovery) offers a natural regression pathway that is not available for the structural forms.

Palmar erythema — the companion sign sharing the hyperestrogenemia mechanism — presents as bilaterally symmetric erythema of the thenar and hypothenar eminences, sometimes extending to the finger pads. It reflects estrogen-driven arteriolar dilation in the palmar microvasculature. Like spider naevi, palmar erythema may partially regress with hepatic recovery but is fixed in advanced or irreversible liver disease.

Treatment of non-regressing hepatic spider naevi. Spider naevi that persist after hepatic recovery — or that are symptomatic in active liver disease — are amenable to the same vascular modalities detailed below: KTP 532 nm laser, PDL 585–595 nm, and electrodesiccation of the central feeding arteriole. The pulsating arteriolar center is the anatomical target; electrodesiccation of this feeding vessel achieves ablation with a single point application — clinically distinct from treating the linear or matted vessels of photodamage-associated forms. Cross-links: liver, liver-fibrosis (fibrosis–VEGF context); rosacea, erythema (non-hepatic causes of facial vascular change).

Mechanisms and aging relevance

Telangiectasia formation in aging converges on two themes: structural perivascular support failure (dominant for UV-induced and leg forms) and sustained vasodilatory drive with secondary ectasia (dominant in rosacea), often superimposed.

UV and the perivascular ECM axis

Dermal blood vessels are held in functional caliber by a perivascular sheath of fibrillar collagen I/III and elastic tissue — the same fibrous scaffold that gives youthful dermis its turgor. The UV→AP-1→MMP upregulation axis documented on skin-aging (Fisher 1996 16) degrades this perivascular support matrix. When perivascular collagen and elastin are fragmented, vessels can no longer be mechanically maintained in their collapsed, toned state; they dilate passively under arterial/capillary pressure and become fixed (ectatic) because the surrounding matrix cannot restore normal caliber. This pathway is the same axis driving wrinkle formation and skin laxity — telangiectasia is one of its downstream vascular readouts. The photodistribution (central face, décolletage, dorsal hands) closely matches that of other photoaging stigmata, confirming the shared UV-dependent mechanism.

Senescence-associated angiogenic milieu

Senescent dermal fibroblasts accumulate in photoaged skin and drive a SASP (senescence-associated secretory phenotype) that includes VEGF, MMP-1, MMP-3, IL-6, and IL-1β — a combination that simultaneously weakens the perivascular matrix and provides a pro-angiogenic background (see cellular-senescence, skin-aging). This SASP-driven, VEGF-rich milieu plausibly sustains vessel ectasia by inhibiting spontaneous resolution and by opposing the fibrous rebuild needed to restore perivascular support. The mechanistic parallel to the cherry-angioma angiogenic environment is notable — both converge on a senescence-rich aged dermis — though cherry angiomas arise from somatic mutation-driven endothelial proliferation while telangiectasias arise from ectasia of existing vessels without neoplastic endothelial expansion. gap/no-mechanism for the quantitative contribution of SASP-derived VEGF to fixed facial telangiectasia in humans (vs simple mechanical perivascular matrix failure as the dominant cause).

Hormonal influences

Estrogens increase cutaneous vascularity and promote vascular smooth-muscle relaxation. This likely underlies the female predominance of facial spider telangiectasias and the de novo appearance or worsening during pregnancy and with oral contraceptive use 17. The clinical observation that rosacea telangiectasia often worsen or first appear around menopause, when estrogen withdrawal alters cutaneous vascular tone, is consistent but has not been definitively studied with a controlled design. Estrogen and progesterone receptor expression is notably absent from post-sclerotherapy telangiectatic matting lesions, suggesting sex hormones influence telangiectasia indirectly (via background vascular tone and neoangiogenesis signals) rather than acting through direct endothelial receptor activation 18. gap/contradictory-evidence for the net direction of hormonal effect on telangiectasia severity at menopause.

Treatment and reversal

Selective photothermolysis: the mechanistic principle

All vascular laser and light therapies for telangiectasia exploit the selective photothermolysis framework 1: select a wavelength maximally absorbed by the target chromophore (oxyhemoglobin absorption peaks at 418, 542, and 577 nm), deliver it in a pulse duration shorter than the thermal relaxation time of the target vessel diameter, and heat is confined within the vessel lumen with minimal lateral diffusion to the surrounding dermis.

ModalityWavelengthPrimary targetsNotes
Pulsed-dye laser (PDL)585–595 nmSuperficial 0.1–0.5 mm vessels; facial telangiectasia; rosaceaHistorical standard; post-treatment purpura common at higher energies; newer long-pulse modes (6–10 ms) reduce purpura
KTP / frequency-doubled Nd:YAG532 nmFine superficial vessels; facial and nasal telangiectasiaLong-pulse 532 nm: 75–100% clearance in 90% of patients in one prospective series 19; strong oxyhemoglobin absorption
Long-pulsed Nd:YAG1064 nmLarger or deeper vessels; leg telangiectasia; resistant casesDeeper penetration (3–5 mm); effective for vessels >0.5 mm and for vessels unresponsive to shorter wavelengths; more patient discomfort
Intense pulsed light (IPL)500–1200 nm (broadband, filtered)Broad spectrum; telangiectasia + dyspigmentation (simultaneous)First-line for poikiloderma of Civatte; cost-effective; operator-dependent; less wavelength-specific than lasers
Pro-yellow (577 nm CW/pulsed)577 nmSuperficial vessels; rosacea erythemaTargets the 577 nm oxyhemoglobin peak directly; emerging data in poikiloderma and rosacea

Multiple sessions are typically required; one to three sessions achieve substantial clearance in most cases, with response modulated by vessel diameter, depth, location (nasal tip is most treatment-resistant due to arterial supply), and skin phototype (higher phototypes require conservative parameters to avoid melanin absorption and post-inflammatory hyperpigmentation).

What does not work for fixed telangiectasia: Topical brimonidine (0.33% gel) achieves high-certainty temporary reduction of diffuse facial erythema via alpha-2 adrenergic vasoconstriction but does not clear structurally ectatic telangiectasias 4 — the vessels are permanently dilated, not transiently vasodilated, and re-appear within hours of drug discontinuation. Brimonidine is a redness-masking agent, not a treatment for fixed vascular lesions.

Sclerotherapy for leg telangiectasias

Chemical sclerotherapy — injection of a sclerosant directly into the vessel lumen — induces endothelial injury, thrombosis, and fibrotic obliteration. Clearance rates of 50–100% are achievable depending on the agent, concentration, and vessel caliber 7. Evidence-based consensus recommends sclerotherapy as first-line for leg telangiectasias and reticular veins, with agents including sodium tetradecyl sulfate (STS), polidocanol, and hypertonic saline 8. Microsclerotherapy (injection under magnification or transillumination) improves precision for very fine vessels. Foam sclerotherapy is used for larger reticular veins feeding the telangiectasia clusters.

Telangiectatic matting — a fine blush of new vessels appearing around treated sites in 10–15% of cases — usually resolves spontaneously within months; risk is increased with overly concentrated sclerosant or excessive injection volume. See chronic-venous-disease for the broader CEAP staging context.

Hallmark mapping

HallmarkRole in telangiectasia
altered-intercellular-communicationPrimary: UV→MMP/TIMP imbalance fragments perivascular collagen and elastin; SASP amplifies the pro-remodeling and pro-angiogenic milieu in aged dermis
cellular-senescenceSenescent dermal fibroblasts accumulate in photoaged skin, secreting VEGF, MMP-1, MMP-3, IL-6; senescent endothelial cells may impair vascular tone regulation
chronic-inflammationInflammaging provides permissive background; rosacea-specific innate immune activation (TLR-2/kallikrein-5 cascade + mast cell activation) drives persistent vasodilation → eventual structural ectasia in ETR subtype

Limitations and gaps

  • Perivascular collagen density vs telangiectasia density in UV-aged vs sun-protected skin: the perivascular support hypothesis is mechanistically sound and textbook-grade but is not anchored to a single primary-source study with verified numeric data in this draft. gap/unsourced gap/needs-replication
  • SASP-VEGF causal contribution to fixed facial telangiectasia has not been directly demonstrated; the mechanistic case is inferential from senescent fibroblast SASP profiling. gap/no-mechanism
  • Long-term recurrence rates after laser/IPL therapy are not well-characterized in randomized data; most clinical series report 1–6 month outcomes with limited follow-up. New telangiectasias can form in adjacent areas even after treated vessels are ablated, particularly if the UV-exposure or rosacea trigger persists. gap/long-term-unknown
  • Procedural device detail now lives on the canonical vascular-laser page (selective photothermolysis, modality comparison); this phenotype page remains the clinical-context anchor and cross-links it for treatment specifics.
  • Model organisms: telangiectasia has no well-validated spontaneous animal model; mouse skin lacks the human facial anatomy and thermoregulatory vascular geometry. Evidence for the UV→MMP mechanism is conserved in rodent photoaging models but treatment-calibration is purely clinical. gap/needs-human-replication is not applicable here (this is already a human-primary phenotype), but cross-species mechanistic validation of the SASP-vascular axis is limited.
  • The rosacea page ([[rosacea]]) was flagged as pending at time of seeding; cross-link should be confirmed after that page is live.

Footnotes

Footnotes

  1. doi:10.1126/science.6836297 · Anderson RR, Parrish JA · Science 1983;220(4596):524–527 · PMID 6836297 · foundational selective-photothermolysis theory: suitably brief pulses of selectively absorbed radiation cause selective damage to the target (vessels or melanosomes) while sparing surrounding tissue; 577 nm demonstrated for selective microvascular damage in human skin · in-vivo + in-vitro · cited >2,800 times (Crossref confirmed) ↩ ↩2

  2. doi:10.1046/j.1524-4725.2000.00060.x · Weiss RA, Goldman MP · Dermatol Surg 2000;26(11):978–982 · PMID 10971554 · prospective case series · n=135 patients with poikiloderma of Civatte (neck/chest) · IPL: >75% clearance of telangiectasias and hyperpigmentation; low side-effect rate; textural improvement noted · closed-access ↩

  3. doi:10.1097/00006534-200105000-00009 · Goldman MP, Weiss RA · Plast Reconstr Surg 2001;107(6):1376–1382 · PMID 11335804 · prospective case series · IPL for neck poikiloderma of Civatte; 50–75% improvement after mean 2.8 treatments; 5% hypopigmentation rate; treatment safety for the neck area demonstrated · closed-access ↩

  4. doi:10.1111/bjd.17590 · van Zuuren EJ et al. · Br J Dermatol 2019;181(1):65–79 · PMID 30585305 · systematic review with GRADE assessments · rosacea phenotype-based interventions: laser/IPL achieves low-to-moderate certainty evidence for erythema/telangiectasia; topical brimonidine: high certainty for temporary erythema reduction but does not clear fixed telangiectasias; laser/light is the only durable modality for fixed vessels ↩ ↩2 ↩3

  5. Maurins U et al. (Bonn Vein Study) · doi:10.1016/j.jvs.2008.04.029 · J Vasc Surg 2008;48(3):680–687 · PMID 18586443 · population-based, n=3,016, ages 18–79 · CEAP highest-stage distribution: C0 9.6% / C1 (telangiectasias + reticular veins) 59.0% / C2 (varicose veins) 14.3% / C3 13.5%; data also cited via chronic-venous-disease [^maurins] · verified against abstract ↩

  6. Criqui MH et al. (San Diego Population Study) · doi:10.1093/aje/kwg166 · Am J Epidemiol 2003;158(5):448–456 · PMID 12936900 · observational, multiethnic, duplex-based · n=2,211 · women vs men spider veins OR 5.36 (age- and ethnicity-adjusted); varicose veins OR 2.18; trophic skin changes less common in women; data also cited via chronic-venous-disease [^criqui] ↩

  7. doi:10.1111/j.1524-4725.1993.tb00976.x · Goldman MP, Fitzpatrick RE · J Dermatol Surg Oncol 1993;19(2):135–138 · PMID 8408908 · review · facial telangiectasia treatment with sclerotherapy, laser surgery, and/or electrodesiccation; sclerotherapy + laser achieve 50–100% resolution rates; combined approaches reduce recurrence and complications compared with electrosurgery alone · closed-access ↩ ↩2

  8. doi:10.1097/dss.0000000000000225 · Weiss MA et al. · Dermatol Surg 2014;40(11):1190–1206 · PMID 25418805 · evidence-based consensus statement · sclerotherapy for varicose and telangiectatic leg veins: patient selection, diagnosis, treatment techniques, choice of sclerosant (STS, polidocanol, hypertonic saline/dextrose), complication management; sclerotherapy recommended as first-line for leg telangiectasias and reticular veins ↩ ↩2

  9. doi:10.1016/j.jceh.2023.101308 · Gandotra A, Taneja S, Premkumar M et al. · J Clin Exp Hepatol 2024 · PMID 38261889 · case report · spider angioma of the lower lip causing bleeding in decompensated cirrhosis; reports 30–40% prevalence and ~95% specificity for cirrhosis; pathogenesis ascribed to elevated substance P and VEGF driving arteriolar dilation and neoangiogenesis · case report only — cited for epidemiological figures and mechanism summary, not primary endpoint data ↩

  10. doi:10.1007/BF02782811 · PMID 1916151 · Maruyama Y, Adachi Y, Aoki N, Suzuki Y, Shinohara H, Yamamoto T · Gastroenterol Jpn 1991;26(4):435–439 · cross-sectional · n=50 male nonalcoholic cirrhotic patients (30 compensated + 20 decompensated) + age-matched healthy controls · elevated SHBG in cirrhosis suppresses free testosterone proportionally more than free estradiol; elevated free estradiol/free testosterone ratio documented in patients with gynecomastia, palmar erythema, or vascular spider; effect more marked in decompensated vs compensated disease · closed-access · abstract-level verification only ↩

  11. doi:10.1080/003655299750026272 · PMID 10423070 · Li CP, Lee FY, Hwang SJ et al. · Scand J Gastroenterol 1999;34(5):520–523 · cross-sectional · n=82 cirrhotic patients + 18 healthy controls · 27/82 (33%) had spider angiomas · elevated free estradiol/testosterone ratios in cirrhotics vs controls; spider angioma patients younger (56 ± 3 vs 66 ± 1 y) with higher bilirubin and higher alcoholism prevalence (41% vs 20%) · stepwise logistic regression: alcoholism (OR 3.5, 95% CI 1.2–10.8, p=0.03) and bilirubin (OR 2.8, 95% CI 1.3–5.7, p=0.006) the only significant independent predictors · closed-access · abstract-level verification only ↩ ↩2

  12. doi:10.1111/j.1572-0241.1999.883_l.x · PMID 10022654 · Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, Hou MC, Chu CJ, Chan CC, Luo JC, Lee SD · Am J Gastroenterol 1999;94(2):502–507 · cross-sectional · n=60 nonalcoholic cirrhotic patients + 20 healthy controls (16/60 = 27% with spider angiomas) · model: human nonalcoholic liver cirrhosis · substance P the only significant independent predictor of spider angioma presence in stepwise logistic regression (OR 3.0, 95% CI 1.4–6.6, p=0.01); sex hormone ratios and nitrate/nitrite were not retained · plasma substance P median 29.2 (cirrhotics) vs 12.3 pg/mL (controls; ~2.4-fold by medians); highest in those with spider angiomas (median 53.1 pg/mL) · closed-access · abstract-level verification only ↩

  13. doi:10.3748/wjg.v9.i12.2832 · PMID 14669345 · Li CP, Lee FY, Hwang SJ et al. · World J Gastroenterol 2003;9(12):2832–2835 · cross-sectional · n=86 cirrhotic patients (mixed etiology: HBV 43%, HCV 21%, alcohol 14%, HBV+alcohol 8%, HCV+alcohol 7%, other 7%) + 53 healthy controls · 31/86 (36%) with spider angiomas · VEGF 185 ± 28 pg/mL (spider+) vs 90 ± 10 pg/mL (spider−); controls 71 ± 11 pg/mL · bFGF 6.8 ± 1.0 pg/mL (spider+) vs 4.1 ± 0.5 pg/mL (spider−) · multivariate logistic regression: young age ≤60 y (OR 6.64, 95% CI 2.02–21.79, p=0.002), VEGF ≥134 pg/mL (OR 4.35, 95% CI 1.35–14.01, p=0.014), and bFGF ≥4.8 pg/mL (OR 5.66, 95% CI 1.72–18.63, p=0.004) were the three independent predictors · verified against full PDF ↩

  14. doi:10.1002/hep.1840030602 · PMID 6629318 · Orrego H, Israel Y, Blake JE, Medline A · Hepatology 1983;3(6):896–905 · prospective observational · n=253 patients with alcoholic liver disease (51 deaths within 1 year) · spider naevi univariately associated with higher 1-year mortality risk and contribute to the additive CCLI severity score; however, in the paper’s stepwise discriminant function analysis and logistic regression, spider nevi were NOT retained as independent predictors — retained independent predictors were encephalopathy, albumin, prothrombin time, and hemoglobin · closed-access · abstract-level verification only ↩

  15. doi:10.1016/s0399-8320(05)88170-9 · PMID 16435503 · Dib N, Konate A, Oberti F, Calès P · Gastroentérol Clin Biol 2005;29(10):975–987 · narrative review (article in French, English abstract) · spider naevi listed among potential predictive factors for oesophageal varices in noninvasive assessment of portal hypertension, but authors note “these data require validation”; formal sensitivity/specificity metrics not isolated · cited for clinical severity-correlation claim only · closed-access · abstract-level verification only ↩

  16. mechanism documented on skin-aging · foundational reference: Fisher JS et al. · doi:10.1073/pnas.93.23.12649 · PNAS 1996;93(23):12649–12654 · UV→AP-1→MMP-1/MMP-3 upregulation → collagen/elastin fragmentation in human dermis; verified against primary PDF (skin-aging.md verified 2026-05-05) · the perivascular fibrous scaffold is subject to the same MMP-driven degradation as the broader dermal collagen network ↩

  17. PMID 2974837 · Foldes EG · Int J Clin Pharmacol Ther Toxicol 1988;26(7):356–359 · review/narrative · estrogenic oral contraceptives increase skin photosensitivity and induce telangiectasia (“estrogenic substances increase the sensitivity of the skin to light and induce telangiectasia” — abstract confirmed); documents dermatological side-effects of hormonal contraceptives including vascular changes · closed-access · abstract-level verification only ↩

  18. doi:10.1046/j.1524-4725.1999.99026.x · PMID 10469110 · Sadick NS, Urmacher C · Dermatol Surg 1999;25(7):539–543 · observational, biopsy-based · n=10 women with post-sclerotherapy telangiectatic matting · biopsies show 0/10 positive for estrogen/progesterone receptors (ERICA/PRICA technique); estrogen/progesterone likely act indirectly on post-sclerotherapy neoangiogenesis (vasodilatory or cytokine-mediated) rather than via direct endothelial receptor activation · closed-access ↩

  19. doi:10.1111/j.1524-4725.1998.tb04055.x · PMID 9464292 · Adrian RM, Tanghetti EA · Dermatol Surg 1998;24(1):71–74 · prospective · n=40 patients with facial telangiectasia · variable-pulse 532 nm Nd:YAG laser with water-cooled sapphire contact cooling: 75–100% clearance in 90% of patients after single treatment; no significant side effects · abstract-verified (cross-checked 2026-06-27 during vascular-laser seeding: n corrected 20→40, DOI resolved) ↩

Graph View

Backlinks